|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
78 a.a.
|
 |
|
|
|
|
|
|
|
(+ 1 more)
79 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hypothetical protein
|
 |
|
Title:
|
 |
The crystal structure of sars coronavirus orf-9b protein
|
|
Structure:
|
 |
Hypothetical protein 5. Chain: a. Synonym: orf-9b, orf13. Engineered: yes. Hypothetical protein 5. Chain: b. Synonym: orf-9b, orf13. Engineered: yes. Other_details: contains lipid molecule (modelled as decane, residue
|
|
Source:
|
 |
Human sars coronavirus. Sars. Organism_taxid: 227859. Strain: hku-39849. Cell_line: vero e6. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.266
|
R-free:
|
0.289
|
|
|
Authors:
|
 |
C.Meier,A.R.Aricescu,R.Assenberg,R.T.Aplin,R.J.C.Gilbert,J.M.Grimes, D.I.Stuart
|
Key ref:
|
 |
C.Meier
et al.
(2006).
The crystal structure of ORF-9b, a lipid binding protein from the SARS coronavirus.
Structure,
14,
1157-1165.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-May-06
|
Release date:
|
19-Jul-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D, E, F, G, H:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
14:1157-1165
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of ORF-9b, a lipid binding protein from the SARS coronavirus.
|
|
C.Meier,
A.R.Aricescu,
R.Assenberg,
R.T.Aplin,
R.J.Gilbert,
J.M.Grimes,
D.I.Stuart.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
To achieve the greatest output from their limited genomes, viruses frequently
make use of alternative open reading frames, in which translation is initiated
from a start codon within an existing gene and, being out of frame, gives rise
to a distinct protein product. These alternative protein products are, as yet,
poorly characterized structurally. Here we report the crystal structure of
ORF-9b, an alternative open reading frame within the nucleocapsid (N) gene from
the SARS coronavirus. The protein has a novel fold, a dimeric tent-like beta
structure with an amphipathic surface, and a central hydrophobic cavity that
binds lipid molecules. This cavity is likely to be involved in membrane
attachment and, in mammalian cells, ORF-9b associates with intracellular
vesicles, consistent with a role in the assembly of the virion. Analysis of
ORF-9b and other overlapping genes suggests that they provide snapshots of the
early evolution of novel protein folds.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. The Structure of the SARS-CoV Genome
Alternative open reading frames (ORF-3b, -7b, -8b, and -9b) are
highlighted in gray. The nucleocapsid (N) gene including its
internal alternative open reading frame, ORF-9b, is shown in an
enlarged representation. S, spike protein; 3, ORF-3; E, envelope
protein; M, membrane protein; 6, ORF-6; 7, ORF-7; 8, ORF-8; N,
nucleocapsid protein (adapted from Snijder et al., 2003; genome
representation is not to scale).
|
 |
Figure 5.
Figure 5. The Structural Evolution of Alternative Open
Reading Frames in Viruses (A) The evolution of
coronaviruses (adapted from Snijder et al., 2003). Based on
their genome sequence, coronaviruses fall into three main
groups. SARS-CoV is thought to be an early split-off from the
group 2 lineage (indicated by a dashed circle). Alternative open
reading frames of the nucleocapsid gene are found only in group
2 viruses, such as MHV and BCV (Senanayake and Brian, 1997), as
well as group 2-related viruses, including SARS-CoV. BCV, bovine
coronavirus; HCoV-229E, human coronavirus 229E; IBV, infectious
bronchitis virus; MHV, murine hepatitis virus; PDEV, porcine
epidemic diarrhea virus; SARS-CoV, severe acute respiratory
syndrome coronavirus; TGEV, transmissible gastroenteritis virus.
(B) A model for the structural evolution of ORF-9b within
the SARS-CoV N-gene. Starting from an N-gene without an
alternative ORF, the protein first arises as an “accidental”
translation product, which is mostly unstructured. By gradual
constrained evolution, it becomes increasingly structured,
eventually attaining its present fold. In this scheme,
disordered regions (colored in red) are a relict of the
evolutionary trajectory of the protein. The N-protein is
represented as a composite of two NMR structures of its
well-conserved N- and C-terminal domains ([Chang et al., 2005a]
and [Huang et al., 2004]), which are thought to be surrounded by
flexible linkers (Chang et al., 2005b) (colored in red). The
region of the N-terminal domain which overlaps with ORF-9b is
shown in green. (C) For comparison, an illustration of the
HIV1 vpu and env genes, which partially overlap. The NMR
structure of the overlapping portion of VPU (Willbold et al.,
1997) (PDB code: 1VPU) is shown. This protein is relatively
poorly ordered (rmsd = 1.6 Å between multiple
determinations of the fold, for all Cα atoms). The least
ordered regions (rmsd > 2 Å) are highlighted in red.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Structure
(2006,
14,
1157-1165)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Rancurel,
M.Khosravi,
A.K.Dunker,
P.R.Romero,
and
D.Karlin
(2009).
Overlapping genes produce proteins with unusual sequence properties and offer insight into de novo protein creation.
|
| |
J Virol,
83,
10719-10736.
|
 |
|
|
|
|
 |
J.Zhao,
A.Falcón,
H.Zhou,
J.Netland,
L.Enjuanes,
P.Pérez Breña,
and
S.Perlman
(2009).
Severe acute respiratory syndrome coronavirus protein 6 is required for optimal replication.
|
| |
J Virol,
83,
2368-2373.
|
 |
|
|
|
|
 |
B.Bakrac,
I.Gutiérrez-Aguirre,
Z.Podlesek,
A.F.Sonnen,
R.J.Gilbert,
P.Macek,
J.H.Lakey,
and
G.Anderluh
(2008).
Molecular determinants of sphingomyelin specificity of a eukaryotic pore-forming toxin.
|
| |
J Biol Chem,
283,
18665-18677.
|
 |
|
|
|
|
 |
B.Canard,
J.S.Joseph,
and
P.Kuhn
(2008).
International research networks in viral structural proteomics: again, lessons from SARS.
|
| |
Antiviral Res,
78,
47-50.
|
 |
|
|
|
|
 |
K.Narayanan,
C.Huang,
and
S.Makino
(2008).
SARS coronavirus accessory proteins.
|
| |
Virus Res,
133,
113-121.
|
 |
|
|
|
|
 |
M.Bartlam,
X.Xue,
and
Z.Rao
(2008).
The search for a structural basis for therapeutic intervention against the SARS coronavirus.
|
| |
Acta Crystallogr A,
64,
204-213.
|
 |
|
|
|
|
 |
M.L.Dediego,
L.Pewe,
E.Alvarez,
M.T.Rejas,
S.Perlman,
and
L.Enjuanes
(2008).
Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice.
|
| |
Virology,
376,
379-389.
|
 |
|
|
|
|
 |
A.von Brunn,
C.Teepe,
J.C.Simpson,
R.Pepperkok,
C.C.Friedel,
R.Zimmer,
R.Roberts,
R.Baric,
and
J.Haas
(2007).
Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome.
|
| |
PLoS ONE,
2,
e459.
|
 |
|
|
|
|
 |
C.Tangudu,
H.Olivares,
J.Netland,
S.Perlman,
and
T.Gallagher
(2007).
Severe acute respiratory syndrome coronavirus protein 6 accelerates murine coronavirus infections.
|
| |
J Virol,
81,
1220-1229.
|
 |
|
|
|
|
 |
K.L.Maxwell,
and
L.Frappier
(2007).
Viral proteomics.
|
| |
Microbiol Mol Biol Rev,
71,
398-411.
|
 |
|
|
|
|
 |
M.Bartlam,
Y.Xu,
and
Z.Rao
(2007).
Structural proteomics of the SARS coronavirus: a model response to emerging infectious diseases.
|
| |
J Struct Funct Genomics,
8,
85-97.
|
 |
|
|
|
|
 |
V.C.Cheng,
S.K.Lau,
P.C.Woo,
and
K.Y.Yuen
(2007).
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.
|
| |
Clin Microbiol Rev,
20,
660-694.
|
 |
|
|
|
|
 |
T.S.Walter,
C.Meier,
R.Assenberg,
K.F.Au,
J.Ren,
A.Verma,
J.E.Nettleship,
R.J.Owens,
D.I.Stuart,
and
J.M.Grimes
(2006).
Lysine methylation as a routine rescue strategy for protein crystallization.
|
| |
Structure,
14,
1617-1622.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |